サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1424052

副腎皮質ステロイド市場、シェア、規模、動向、産業分析レポート：タイプ別、投与経路別、用途別、地域別、セグメント別予測、2024年～2032年

Corticosteroids Market Share, Size, Trends, Industry Analysis Report, By Type (Mineralocorticoids, Glucocorticoids); By Route of Administration; By Application; By Region; Segment Forecast, 2024- 2032
出版日: | 発行: Polaris Market Research | ページ情報: 英文 117 Pages | 納期: 即日から翌営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=157.14円
副腎皮質ステロイド市場、シェア、規模、動向、産業分析レポート：タイプ別、投与経路別、用途別、地域別、セグメント別予測、2024年～2032年
出版日: 2024年01月24日
発行: Polaris Market Research
ページ情報: 英文 117 Pages
納期: 即日から翌営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

Polaris Market Research社の最新調査によると、副腎皮質ステロイドの世界市場規模は2032年までに85億3,000万米ドルに達する見込みです。この調査レポートは、現在の市場力学を詳細に洞察し、将来の市場成長に関する分析を提供しています。

喘息、関節リウマチ、皮膚疾患などの慢性疾患の急増が、副腎皮質ステロイド市場の機会を促進しています。副腎皮質ステロイドは強力な抗炎症作用があるため、これらの疾患の管理に不可欠であり、世界的に需要が高まっています。ライフスタイル要因に後押しされ、効果的な抗炎症ソリューションに対する需要は副腎皮質ステロイドを最前線に位置づけています。医薬品の技術革新は極めて重要であり、企業は特定の慢性疾患に合わせた製剤を開発し、副腎皮質ステロイド市場における標的治療ソリューションのニーズの高まりに応えることができます。

副腎皮質ステロイド市場は、生物学的製剤と併用療法の潜在的な統合によってもたらされる機会を活用しています。標的メカニズムを持つ生物製剤は、副腎皮質ステロイドの広範な抗炎症作用と相乗効果を発揮し、治療成績の向上と副作用の軽減を目指します。自己免疫疾患や炎症性疾患のダイナミックな状況において、多様な治療法は極めて重要です。特定の経路に作用する生物製剤は、副腎皮質ステロイド治療に個別化された次元を加えます。この戦略的な組み合わせは、新しい製剤と治療レジメンの開拓を促進し、複雑な病態を管理するためのより効果的でオーダーメイドの解決策を提供し、副腎皮質ステロイド市場に漸進的な変化をもたらし、治療効果の向上を約束します。

遠隔医療とEヘルスは、副腎皮質ステロイド市場を形成する上でますます重要性を増しており、新たな機会を開いています。ヘルスケアのデジタル化によって遠隔診察が可能になり、副腎皮質ステロイドの処方へのアクセスが容易になった。これらのプラットフォームは、ヘルスケア提供者に患者をモニターする力を与え、副腎皮質ステロイド・レジメンのタイムリーな調整を保証します。

Eヘルスソリューションは情報の流れを合理化し、副腎皮質ステロイドの使用法や副作用に関する患者教育を強化します。このデジタル統合は、患者のアドヒアランスを高めるだけでなく、副腎皮質ステロイド療法の普及を拡大し、特に十分なサービスを受けていない人々に恩恵をもたらします。副腎皮質ステロイド市場は、遠隔医療によってもたらされる利便性と効率性を活用することで、患者中心のアプローチを促進し、イノベーション、データ主導の洞察、ヘルスケアへのアクセス強化の道を開きます。

副腎皮質ホルモン市場レポートハイライト

2023年には、汎用性、慢性疾患の管理、治療の進歩により、グルココルチコイド部門が大きな市場シェアを占めました。

2023年には、全身吸収の抑制、局所治療、他の治療法との適合性により、局所用セグメントが大きな市場シェアを占めました。

2023年には、抗炎症特性、迅速な症状緩和、幅広い用途により、皮膚アレルギーセグメントが大きな収益シェアを占めました。

2023年には、北米地域が、確立された企業、規制環境、進行中の技術進歩、研究開発により、世界市場を独占しました。

AbbVie Inc.、AstraZeneca plc、Bayer AG、Cipla Limited、Eli Lilly and Company、F. Hoffmann-La Roche Ltd.、GlaxoSmithKline plc、Sanofi S.A.など、世界的に存在感を示す市場参入企業が存在するため、市場競争は激しいです。

目次

第1章 イントロダクション

第2章 エグゼクティブサマリー

第3章 調査手法

第4章 世界の副腎皮質ステロイド市場に関する洞察

  • 副腎皮質ステロイド市場 - アプリケーションのスナップショット
  • 副腎皮質ステロイド市場力学
    • 促進要因と機会
      • 医薬品製剤の進歩により、製品の需要が刺激されると予測されています
      • 高齢化人口の増加が市場の成長を促進すると予想される
    • 抑制要因と課題
      • 副作用や副作用が市場の成長を妨げる可能性が高い
  • PESTEL分析
  • 副腎皮質ステロイド市場応用動向
  • バリューチェーン分析
  • COVID-19感染症の影響分析

第5章 世界の副腎皮質ステロイド市場、投与経路別

  • 主な調査結果
  • イントロダクション
  • 吸入
  • 局所
  • 注射
  • 経口

第6章 世界の副腎皮質ステロイド市場、タイプ別

  • 主な調査結果
  • イントロダクション
  • ミネラルコルチコイド
  • 糖質コルチコイド

第7章 世界の副腎皮質ステロイド市場、用途別

  • 主な調査結果
  • イントロダクション
  • 皮膚アレルギー
  • 消化器科
  • 内分泌学
  • 急性呼吸器疾患
  • リウマチの適応症
  • その他

第8章 世界の副腎皮質ステロイド市場、地域別

  • 主な調査結果
  • イントロダクション
    • 副腎皮質ステロイド市場評価、地域別、2019年～2032年
  • 副腎皮質ステロイド市場 - 北米
    • 北米：副腎皮質ステロイド市場、投与経路別、2019年～2032年
    • 北米：副腎皮質ステロイド市場、用途別、2019年～2032年
    • 北米：副腎皮質ステロイド市場、タイプ別、2019年～2032年
    • 副腎皮質ステロイド市場 - 米国
    • 副腎皮質ステロイド市場 - カナダ
  • 副腎皮質ステロイド市場 - 欧州
    • 欧州：副腎皮質ステロイド市場、投与経路別、2019年～2032年
    • 欧州：副腎皮質ステロイド市場、用途別、2019年～2032年
    • 欧州：副腎皮質ステロイド市場、タイプ別、2019年～2032年
    • 副腎皮質ステロイド市場 - 英国
    • 副腎皮質ステロイド市場 - フランス
    • 副腎皮質ステロイド市場 - ドイツ
    • 副腎皮質ステロイド市場 - イタリア
    • 副腎皮質ステロイド市場 - スペイン
    • 副腎皮質ステロイド市場 - オランダ
    • 副腎皮質ステロイド市場 - ロシア
  • 副腎皮質ステロイド市場 - アジア太平洋
    • アジア太平洋：副腎皮質ステロイド市場、投与経路別、2019年～2032年
    • アジア太平洋：副腎皮質ステロイド市場、用途別、2019年～2032年
    • アジア太平洋：副腎皮質ステロイド市場、タイプ別、2019年～2032年
    • 副腎皮質ステロイド市場 - 中国
    • 副腎皮質ステロイド市場 - インド
    • 副腎皮質ステロイド市場 - マレーシア
    • 副腎皮質ステロイド市場 - 日本
    • 副腎皮質ステロイド市場 - インドネシア
    • 副腎皮質ステロイド市場 - 韓国
  • 副腎皮質ステロイド市場 - 中東・アフリカ
    • 中東・アフリカ：副腎皮質ステロイド市場、投与経路別、2019年～2032年
    • 中東・アフリカ：副腎皮質ステロイド市場、用途別、2019年～2032年
    • 中東・アフリカ：副腎皮質ステロイド市場、タイプ別、2019年～2032年
    • 副腎皮質ステロイド市場 - サウジアラビア
    • 副腎皮質ステロイド市場 - アラブ首長国連邦
    • 副腎皮質ステロイド市場 - イスラエル
    • 副腎皮質ステロイド市場 - 南アフリカ
  • 副腎皮質ステロイド市場 - ラテンアメリカ
    • ラテンアメリカ：副腎皮質ステロイド市場、投与経路別、2019年～2032年
    • ラテンアメリカ：副腎皮質ステロイド市場、用途別、2019年～2032年
    • ラテンアメリカ：副腎皮質ステロイド市場、タイプ別、2019年～2032年
    • 副腎皮質ステロイド市場 - メキシコ
    • 副腎皮質ステロイド市場 - ブラジル
    • 副腎皮質ステロイド市場 - アルゼンチン

第9章 競合情勢

  • 拡張と買収の分析
    • 拡大
    • 買収
  • 提携/協業/合意/公開

第10章 企業プロファイル

  • AbbVie Inc.
  • Astellas Pharma Inc.
  • AstraZeneca plc
  • Bausch Health Companies Inc.
  • Bayer AG
  • Cipla Limited
  • Eli Lilly and Company
  • F. Hoffmann-La Roche Ltd.
  • GlaxoSmithKline plc
  • Johnson & Johnson
  • Lupin Limited
  • Merck & Co., Inc.
  • Novartis International AG
  • Pfizer Inc.
  • Sanofi S.A.
図表

List of Tables

  • Table 1 Global Corticosteroids Market, by Route of Administration, 2019-2032 (USD Billion)
  • Table 2 Global Corticosteroids Market, by Type, 2019-2032 (USD Billion)
  • Table 3 Global Corticosteroids Market, by Application, 2019-2032 (USD Billion)
  • Table 4 Corticosteroids Market Assessment, By Geography, 2019-2032 (USD Billion)
  • Table 5 North America: Corticosteroids Market, by Route of Administration, 2019-2032 (USD Billion)
  • Table 6 North America: Corticosteroids Market, by Type, 2019-2032 (USD Billion)
  • Table 7 North America: Corticosteroids Market, by Application, 2019-2032 (USD Billion)
  • Table 8 U.S.: Corticosteroids Market, by Route of Administration, 2019-2032 (USD Billion)
  • Table 9 U.S.: Corticosteroids Market, by Type, 2019-2032 (USD Billion)
  • Table 10 U.S.: Corticosteroids Market, by Application, 2019-2032 (USD Billion)
  • Table 11 Canada: Corticosteroids Market, by Route of Administration, 2019-2032 (USD Billion)
  • Table 12 Canada: Corticosteroids Market, by Type, 2019-2032 (USD Billion)
  • Table 13 Canada: Corticosteroids Market, by Application, 2019-2032 (USD Billion)
  • Table 14 Europe: Corticosteroids Market, by Route of Administration, 2019-2032 (USD Billion)
  • Table 15 Europe: Corticosteroids Market, by Type, 2019-2032 (USD Billion)
  • Table 16 Europe: Corticosteroids Market, by Application, 2019-2032 (USD Billion)
  • Table 17 UK: Corticosteroids Market, by Route of Administration, 2019-2032 (USD Billion)
  • Table 18 UK: Corticosteroids Market, by Type, 2019-2032 (USD Billion)
  • Table 19 UK: Corticosteroids Market, by Application, 2019-2032 (USD Billion)
  • Table 20 France: Corticosteroids Market, by Route of Administration, 2019-2032 (USD Billion)
  • Table 21 France: Corticosteroids Market, by Type, 2019-2032 (USD Billion)
  • Table 22 France: Corticosteroids Market, by Application, 2019-2032 (USD Billion)
  • Table 23 Germany: Corticosteroids Market, by Route of Administration, 2019-2032 (USD Billion)
  • Table 24 Germany: Corticosteroids Market, by Type, 2019-2032 (USD Billion)
  • Table 25 Germany: Corticosteroids Market, by Application, 2019-2032 (USD Billion)
  • Table 26 Italy: Corticosteroids Market, by Route of Administration, 2019-2032 (USD Billion)
  • Table 27 Italy: Corticosteroids Market, by Type, 2019-2032 (USD Billion)
  • Table 28 Italy: Corticosteroids Market, by Application, 2019-2032 (USD Billion)
  • Table 29 Spain: Corticosteroids Market, by Route of Administration, 2019-2032 (USD Billion)
  • Table 30 Spain: Corticosteroids Market, by Type, 2019-2032 (USD Billion)
  • Table 31 Spain: Corticosteroids Market, by Application, 2019-2032 (USD Billion)
  • Table 32 Netherlands: Corticosteroids Market, by Route of Administration, 2019-2032 (USD Billion)
  • Table 33 Netherlands: Corticosteroids Market, by Type, 2019-2032 (USD Billion)
  • Table 34 Netherlands: Corticosteroids Market, by Application, 2019-2032 (USD Billion)
  • Table 35 Russia: Corticosteroids Market, by Route of Administration, 2019-2032 (USD Billion)
  • Table 36 Russia: Corticosteroids Market, by Type, 2019-2032 (USD Billion)
  • Table 37 Russia: Corticosteroids Market, by Application, 2019-2032 (USD Billion)
  • Table 38 Asia Pacific: Corticosteroids Market, by Route of Administration, 2019-2032 (USD Billion)
  • Table 39 Asia Pacific: Corticosteroids Market, by Type, 2019-2032 (USD Billion)
  • Table 40 Asia Pacific: Corticosteroids Market, by Application, 2019-2032 (USD Billion)
  • Table 41 China: Corticosteroids Market, by Route of Administration, 2019-2032 (USD Billion)
  • Table 42 China: Corticosteroids Market, by Type, 2019-2032 (USD Billion)
  • Table 43 China: Corticosteroids Market, by Application, 2019-2032 (USD Billion)
  • Table 44 India: Corticosteroids Market, by Route of Administration, 2019-2032 (USD Billion)
  • Table 45 India: Corticosteroids Market, by Type, 2019-2032 (USD Billion)
  • Table 46 India: Corticosteroids Market, by Application, 2019-2032 (USD Billion)
  • Table 47 Malaysia: Corticosteroids Market, by Route of Administration, 2019-2032 (USD Billion)
  • Table 48 Malaysia: Corticosteroids Market, by Type, 2019-2032 (USD Billion)
  • Table 49 Malaysia: Corticosteroids Market, by Application, 2019-2032 (USD Billion)
  • Table 50 Japan: Corticosteroids Market, by Route of Administration, 2019-2032 (USD Billion)
  • Table 51 Japan: Corticosteroids Market, by Type, 2019-2032 (USD Billion)
  • Table 52 Japan: Corticosteroids Market, by Application, 2019-2032 (USD Billion)
  • Table 53 Indonesia: Corticosteroids Market, by Route of Administration, 2019-2032 (USD Billion)
  • Table 54 Indonesia: Corticosteroids Market, by Type, 2019-2032 (USD Billion)
  • Table 55 Indonesia: Corticosteroids Market, by Application, 2019-2032 (USD Billion)
  • Table 56 South Korea: Corticosteroids Market, by Route of Administration, 2019-2032 (USD Billion)
  • Table 57 South Korea: Corticosteroids Market, by Type, 2019-2032 (USD Billion)
  • Table 58 South Korea: Corticosteroids Market, by Application, 2019-2032 (USD Billion)
  • Table 59 Middle East & Africa: Corticosteroids Market, by Route of Administration, 2019-2032 (USD Billion)
  • Table 60 Middle East & Africa: Corticosteroids Market, by Type, 2019-2032 (USD Billion)
  • Table 61 Middle East & Africa: Corticosteroids Market, by Application, 2019-2032 (USD Billion)
  • Table 62 Saudi Arabia: Corticosteroids Market, by Route of Administration, 2019-2032 (USD Billion)
  • Table 63 Saudi Arabia: Corticosteroids Market, by Type, 2019-2032 (USD Billion)
  • Table 64 Saudi Arabia: Corticosteroids Market, by Application, 2019-2032 (USD Billion)
  • Table 65 UAE: Corticosteroids Market, by Route of Administration, 2019-2032 (USD Billion)
  • Table 66 UAE: Corticosteroids Market, by Type, 2019-2032 (USD Billion)
  • Table 67 UAE: Corticosteroids Market, by Application, 2019-2032 (USD Billion)
  • Table 68 Israel: Corticosteroids Market, by Route of Administration, 2019-2032 (USD Billion)
  • Table 69 Israel: Corticosteroids Market, by Type, 2019-2032 (USD Billion)
  • Table 70 Israel: Corticosteroids Market, by Application, 2019-2032 (USD Billion)
  • Table 71 South Africa: Corticosteroids Market, by Route of Administration, 2019-2032 (USD Billion)
  • Table 72 South Africa: Corticosteroids Market, by Type, 2019-2032 (USD Billion)
  • Table 73 South Africa: Corticosteroids Market, by Application, 2019-2032 (USD Billion)
  • Table 74 Latin America: Corticosteroids Market, by Route of Administration, 2019-2032 (USD Billion)
  • Table 75 Latin America: Corticosteroids Market, by Type, 2019-2032 (USD Billion)
  • Table 76 Latin America: Corticosteroids Market, by Application, 2019-2032 (USD Billion)
  • Table 77 Mexico: Corticosteroids Market, by Route of Administration, 2019-2032 (USD Billion)
  • Table 78 Mexico: Corticosteroids Market, by Type, 2019-2032 (USD Billion)
  • Table 79 Mexico: Corticosteroids Market, by Application, 2019-2032 (USD Billion)
  • Table 80 Brazil: Corticosteroids Market, by Route of Administration, 2019-2032 (USD Billion)
  • Table 81 Brazil: Corticosteroids Market, by Type, 2019-2032 (USD Billion)
  • Table 82 Brazil: Corticosteroids Market, by Application, 2019-2032 (USD Billion)
  • Table 83 Argentina: Corticosteroids Market, by Route of Administration, 2019-2032 (USD Billion)
  • Table 84 Argentina: Corticosteroids Market, by Type, 2019-2032 (USD Billion)
  • Table 85 Argentina: Corticosteroids Market, by Application, 2019-2032 (USD Billion)

List of Figures

  • Figure 1. Global Corticosteroids Market, 2019-2032 (USD Billion)
  • Figure 2. Integrated Ecosystem
  • Figure 3. Research Methodology: Top-Down & Bottom-Up Approach
  • Figure 4. Market by Geography
  • Figure 5. Porter's Five Forces
  • Figure 6. Market by Type
  • Figure 7. Global Corticosteroids Market, by Type, 2022 & 2032 (USD Billion)
  • Figure 8. Market by Route of Administration
  • Figure 9. Global Corticosteroids Market, by Route of Administration, 2022 & 2032 (USD Billion)
  • Figure 10. Market by Application
  • Figure 11. Global Corticosteroids Market, by Application, 2022 & 2032 (USD Billion)
  • Figure 12. Corticosteroids Market Assessment, By Geography, 2019-2032 (USD Billion)
  • Figure 13. Strategic Analysis - Corticosteroids Market
目次
Product Code: PM4413

The global Corticosteroids market size is expected to reach USD 8.53 billion by 2032, according to a new study by Polaris Market Research. The report "Corticosteroids Market Share, Size, Trends, Industry Analysis Report, By Type (Mineralocorticoids, Glucocorticoids); By Route of Administration; By Application; By Region; Segment Forecast, 2024- 2032" gives a detailed insight into current market dynamics and provides analysis on future market growth.

The surging prevalence of chronic diseases such as asthma, rheumatoid arthritis, and dermatological disorders propels opportunities in the corticosteroids market. Vital for managing these conditions due to their potent anti-inflammatory properties, corticosteroids witness rising demand globally. Fueled by lifestyle factors, the demand for effective anti-inflammatory solutions positions corticosteroids at the forefront. Pharmaceutical innovation becomes crucial, presenting companies with the prospect of developing tailored formulations for specific chronic diseases, meeting the growing need for targeted therapeutic solutions in the corticosteroids market.

The corticosteroids market is capitalizing on opportunities presented by the potential integration of biologics and combination therapies. Biologics, with targeted mechanisms, synergize with the broad anti-inflammatory actions of corticosteroids, aiming for enhanced therapeutic outcomes and reduced side effects. In the dynamic landscape of autoimmune and inflammatory disorders, diversified treatment modalities are crucial. Biologics, addressing specific pathways, add a personalized dimension to corticosteroid treatments. This strategic combination fosters the development of novel formulations and treatment regimens, offering more effective and tailored solutions for managing complex conditions, marking a progressive shift in the corticosteroids market and promising improved therapeutic efficacy.

Telemedicine and E-Health are increasingly pivotal in shaping the corticosteroids market, opening novel opportunities. The digital transformation in healthcare allows for remote consultations, facilitating easier access to corticosteroid prescriptions. These platforms empower healthcare providers to monitor patients, ensuring timely adjustments to corticosteroid regimens.

E-Health solutions streamline information flow, enhancing patient education on corticosteroid usage and side effects. This digital integration not only boosts patient adherence but also broadens the reach of corticosteroid therapies, particularly benefiting underserved populations. The corticosteroids market capitalizes on the convenience and efficiency introduced by telemedicine, fostering a patient-centric approach and creating avenues for innovation, data-driven insights, and enhanced healthcare accessibility.

Corticosteroids Market Report Highlights

In 2023, the glucocorticoids segment accounted for significant market share owing to versatility, management of chronic diseases, and therapeutic advancements.

In 2023, the topical segment accounted for significant market share owing to reduced systemic absorption, localized treatment, and compatibility with other therapies.

In 2023, the skin allergies segment held significant revenue share owing to anti-inflammatory properties, quick symptomatic relief, and wide range of applications.

In 2023, North America region dominated the global market due to established players, regulatory environment, ongoing technological advancements, and research and development.

The market is highly competitive owing to the existence of market players with a global presence, including AbbVie Inc., AstraZeneca plc, Bayer AG, Cipla Limited, Eli Lilly and Company, F. Hoffmann-La Roche Ltd., GlaxoSmithKline plc, and Sanofi S.A. among others.

Polaris Market Research has segmented the Corticosteroids market report based on type, route of administration, application, and region:

Corticosteroids, Type Outlook (Revenue - USD Billion, 2019 - 2032)

  • Mineralocorticoids
  • Glucocorticoids

Corticosteroids, Route of Administration Outlook (Revenue - USD Billion, 2019 - 2032)

  • Inhaled
  • Topical
  • Injectable
  • Oral

Corticosteroids, Application Outlook (Revenue - USD Billion, 2019 - 2032)

  • Skin Allergies
  • Gastroenterology
  • Endocrinology
  • Acute Respiratory Diseases
  • Rheumatology Indications
  • Others

Corticosteroids, Regional Outlook (Revenue - USD Billion, 2019 - 2032)

  • North America
  • U.S.
  • Canada
  • Europe
  • France
  • Germany
  • UK
  • Italy
  • Netherlands
  • Spain
  • Russia
  • Asia Pacific
  • Japan
  • China
  • India
  • Malaysia
  • Indonesia
  • South Korea
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Middle East & Africa
  • Saudi Arabia
  • UAE
  • Israel
  • South Africa

Table of Contents

1. Introduction

  • 1.1. Report Description
    • 1.1.1. Objectives of the Study
    • 1.1.2. Market Scope
    • 1.1.3. Assumptions
  • 1.2. Stakeholders

2. Executive Summary

  • 2.1. Market Highlights

3. Research Methodology

  • 3.1. Overview
    • 3.1.1. Data Mining
  • 3.2. Data Sources
    • 3.2.1. Primary Sources
    • 3.2.2. Secondary Sources

4. Global Corticosteroids Market Insights

  • 4.1. Corticosteroids Market - Application Snapshot
  • 4.2. Corticosteroids Market Dynamics
    • 4.2.1. Drivers and Opportunities
      • 4.2.1.1. Advancements in drug formulations are projected to spur the product demand
      • 4.2.1.2. Rising aging population is expected to drive market growth
    • 4.2.2. Restraints and Challenges
      • 4.2.2.1. Adverse reactions and side effects are likely to impede the market growth
  • 4.3. Porter's Five Forces Analysis
    • 4.3.1. Bargaining Power of Suppliers (Moderate)
    • 4.3.2. Threats of New Entrants: (Low)
    • 4.3.3. Bargaining Power of Buyers (Moderate)
    • 4.3.4. Threat of Substitute (Moderate)
    • 4.3.5. Rivalry among existing firms (High)
  • 4.4. PESTEL Analysis
  • 4.5. Corticosteroids Market Application Trends
  • 4.6. Value Chain Analysis
  • 4.7. COVID-19 Impact Analysis

5. Global Corticosteroids Market, by Route of Administration

  • 5.1. Key Findings
  • 5.2. Introduction
    • 5.2.1. Global Corticosteroids Market, by Route of Administration, 2019-2032 (USD Billion)
  • 5.3. Inhaled
    • 5.3.1. Global Corticosteroids Market, by Inhaled, by Region, 2019-2032 (USD Billion)
  • 5.4. Topical
    • 5.4.1. Global Corticosteroids Market, by Topical, by Region, 2019-2032 (USD Billion)
  • 5.5. Injectable
    • 5.5.1. Global Corticosteroids Market, by Injectable, by Region, 2019-2032 (USD Billion)
  • 5.6. Oral
    • 5.6.1. Global Corticosteroids Market, by Oral, by Region, 2019-2032 (USD Billion)

6. Global Corticosteroids Market, by Type

  • 6.1. Key Findings
  • 6.2. Introduction
    • 6.2.1. Global Corticosteroids Market, by Type, 2019-2032 (USD Billion)
  • 6.3. Mineralocorticoids
    • 6.3.1. Global Corticosteroids Market, by Mineralocorticoids, by Region, 2019-2032 (USD Billion)
  • 6.4. Glucocorticoids
    • 6.4.1. Global Corticosteroids Market, by Glucocorticoids, by Region, 2019-2032 (USD Billion)

7. Global Corticosteroids Market, by Application

  • 7.1. Key Findings
  • 7.2. Introduction
    • 7.2.1. Global Corticosteroids Market, by Application, 2019-2032 (USD Billion)
  • 7.3. Skin Allergies
    • 7.3.1. Global Corticosteroids Market, by Skin Allergies, By Region, 2019-2032 (USD Billion)
  • 7.4. Gastroenterology
    • 7.4.1. Global Corticosteroids Market, by Gastroenterology, By Region, 2019-2032 (USD Billion)
  • 7.5. Endocrinology
    • 7.5.1. Global Corticosteroids Market, by Endocrinology, By Region, 2019-2032 (USD Billion)
  • 7.6. Acute Respiratory Diseases
    • 7.6.1. Global Corticosteroids Market, by Acute Respiratory Diseases, By Region, 2019-2032 (USD Billion)
  • 7.7. Rheumatology Indications
    • 7.7.1. Global Corticosteroids Market, by Rheumatology Indications, By Region, 2019-2032 (USD Billion)
  • 7.8. Others
    • 7.8.1. Global Corticosteroids Market, by Others, By Region, 2019-2032 (USD Billion)

8. Global Corticosteroids Market, by Geography

  • 8.1. Key findings
  • 8.2. Introduction
    • 8.2.1. Corticosteroids Market Assessment, By Geography, 2019-2032 (USD Billion)
  • 8.3. Corticosteroids Market - North America
    • 8.3.1. North America: Corticosteroids Market, by Route of Administration, 2019-2032 (USD Billion)
    • 8.3.2. North America: Corticosteroids Market, by Application, 2019-2032 (USD Billion)
    • 8.3.3. North America: Corticosteroids Market, by Type, 2019-2032 (USD Billion)
    • 8.3.4. Corticosteroids Market - U.S.
      • 8.3.4.1. U.S.: Corticosteroids Market, by Route of Administration, 2019-2032 (USD Billion)
      • 8.3.4.2. U.S.: Corticosteroids Market, by Application, 2019-2032 (USD Billion)
      • 8.3.4.3. U.S.: Corticosteroids Market, by Type, 2019-2032 (USD Billion)
    • 8.3.5. Corticosteroids Market - Canada
      • 8.3.5.1. Canada: Corticosteroids Market, by Route of Administration, 2019-2032 (USD Billion)
      • 8.3.5.2. Canada.: Corticosteroids Market, by Application, 2019-2032 (USD Billion)
      • 8.3.5.3. Canada: Corticosteroids Market, by Type, 2019-2032 (USD Billion)
  • 8.4. Corticosteroids Market - Europe
    • 8.4.1. Europe: Corticosteroids Market, by Route of Administration, 2019-2032 (USD Billion)
    • 8.4.2. Europe.: Corticosteroids Market, by Application, 2019-2032 (USD Billion)
    • 8.4.3. Europe: Corticosteroids Market, by Type, 2019-2032 (USD Billion)
    • 8.4.4. Corticosteroids Market - UK
      • 8.4.4.1. UK: Corticosteroids Market, by Route of Administration, 2019-2032 (USD Billion)
      • 8.4.4.2. UK.: Corticosteroids Market, by Application, 2019-2032 (USD Billion)
      • 8.4.4.3. UK: Corticosteroids Market, by Type, 2019-2032 (USD Billion)
    • 8.4.5. Corticosteroids Market - France
      • 8.4.5.1. France: Corticosteroids Market, by Route of Administration, 2019-2032 (USD Billion)
      • 8.4.5.2. France.: Corticosteroids Market, by Application, 2019-2032 (USD Billion)
      • 8.4.5.3. France: Corticosteroids Market, by Type, 2019-2032 (USD Billion)
    • 8.4.6. Corticosteroids Market - Germany
      • 8.4.6.1. Germany: Corticosteroids Market, by Route of Administration, 2019-2032 (USD Billion)
      • 8.4.6.2. Germany.: Corticosteroids Market, by Application, 2019-2032 (USD Billion)
      • 8.4.6.3. Germany: Corticosteroids Market, by Type, 2019-2032 (USD Billion)
    • 8.4.7. Corticosteroids Market - Italy
      • 8.4.7.1. Italy: Corticosteroids Market, by Route of Administration, 2019-2032 (USD Billion)
      • 8.4.7.2. Italy.: Corticosteroids Market, by Application, 2019-2032 (USD Billion)
      • 8.4.7.3. Italy: Corticosteroids Market, by Type, 2019-2032 (USD Billion)
    • 8.4.8. Corticosteroids Market - Spain
      • 8.4.8.1. Spain: Corticosteroids Market, by Route of Administration, 2019-2032 (USD Billion)
      • 8.4.8.2. Spain.: Corticosteroids Market, by Application, 2019-2032 (USD Billion)
      • 8.4.8.3. Spain: Corticosteroids Market, by Type, 2019-2032 (USD Billion)
    • 8.4.9. Corticosteroids Market - Netherlands
      • 8.4.9.1. Netherlands: Corticosteroids Market, by Route of Administration, 2019-2032 (USD Billion)
      • 8.4.9.2. Netherlands.: Corticosteroids Market, by Application, 2019-2032 (USD Billion)
      • 8.4.9.3. Netherlands: Corticosteroids Market, by Type, 2019-2032 (USD Billion)
    • 8.4.10. Corticosteroids Market - Russia
      • 8.4.10.1. Russia: Corticosteroids Market, by Route of Administration, 2019-2032 (USD Billion)
      • 8.4.10.2. Russia.: Corticosteroids Market, by Application, 2019-2032 (USD Billion)
      • 8.4.10.3. Russia: Corticosteroids Market, by Type, 2019-2032 (USD Billion)
  • 8.5. Corticosteroids Market - Asia Pacific
    • 8.5.1. Asia Pacific: Corticosteroids Market, by Route of Administration, 2019-2032 (USD Billion)
    • 8.5.2. Asia Pacific.: Corticosteroids Market, by Application, 2019-2032 (USD Billion)
    • 8.5.3. Asia Pacific: Corticosteroids Market, by Type, 2019-2032 (USD Billion)
    • 8.5.4. Corticosteroids Market - China
      • 8.5.4.1. China: Corticosteroids Market, by Route of Administration, 2019-2032 (USD Billion)
      • 8.5.4.2. China.: Corticosteroids Market, by Application, 2019-2032 (USD Billion)
      • 8.5.4.3. China: Corticosteroids Market, by Type, 2019-2032 (USD Billion)
    • 8.5.5. Corticosteroids Market - India
      • 8.5.5.1. India: Corticosteroids Market, by Route of Administration, 2019-2032 (USD Billion)
      • 8.5.5.2. India.: Corticosteroids Market, by Application, 2019-2032 (USD Billion)
      • 8.5.5.3. India: Corticosteroids Market, by Type, 2019-2032 (USD Billion)
    • 8.5.6. Corticosteroids Market - Malaysia
      • 8.5.6.1. Malaysia: Corticosteroids Market, by Route of Administration, 2019-2032 (USD Billion)
      • 8.5.6.2. Malaysia.: Corticosteroids Market, by Application, 2019-2032 (USD Billion)
      • 8.5.6.3. Malaysia: Corticosteroids Market, by Type, 2019-2032 (USD Billion)
    • 8.5.7. Corticosteroids Market - Japan
      • 8.5.7.1. Japan: Corticosteroids Market, by Route of Administration, 2019-2032 (USD Billion)
      • 8.5.7.2. Japan.: Corticosteroids Market, by Application, 2019-2032 (USD Billion)
      • 8.5.7.3. Japan: Corticosteroids Market, by Type, 2019-2032 (USD Billion)
    • 8.5.8. Corticosteroids Market - Indonesia
      • 8.5.8.1. Indonesia: Corticosteroids Market, by Route of Administration, 2019-2032 (USD Billion)
      • 8.5.8.2. Indonesia.: Corticosteroids Market, by Application, 2019-2032 (USD Billion)
      • 8.5.8.3. Indonesia: Corticosteroids Market, by Type, 2019-2032 (USD Billion)
    • 8.5.9. Corticosteroids Market - South Korea
      • 8.5.9.1. South Korea: Corticosteroids Market, by Route of Administration, 2019-2032 (USD Billion)
      • 8.5.9.2. South Korea.: Corticosteroids Market, by Application, 2019-2032 (USD Billion)
      • 8.5.9.3. South Korea: Corticosteroids Market, by Type, 2019-2032 (USD Billion)
  • 8.6. Corticosteroids Market - Middle East & Africa
    • 8.6.1. Middle East & Africa: Corticosteroids Market, by Route of Administration, 2019-2032 (USD Billion)
    • 8.6.2. Middle East & Africa.: Corticosteroids Market, by Application, 2019-2032 (USD Billion)
    • 8.6.3. Middle East & Africa: Corticosteroids Market, by Type, 2019-2032 (USD Billion)
    • 8.6.4. Corticosteroids Market - Saudi Arabia
      • 8.6.4.1. Saudi Arabia: Corticosteroids Market, by Route of Administration, 2019-2032 (USD Billion)
      • 8.6.4.2. Saudi Arabia.: Corticosteroids Market, by Application, 2019-2032 (USD Billion)
      • 8.6.4.3. Saudi Arabia: Corticosteroids Market, by Type, 2019-2032 (USD Billion)
    • 8.6.5. Corticosteroids Market - UAE
      • 8.6.5.1. UAE: Corticosteroids Market, by Route of Administration, 2019-2032 (USD Billion)
      • 8.6.5.2. UAE.: Corticosteroids Market, by Application, 2019-2032 (USD Billion)
      • 8.6.5.3. UAE: Corticosteroids Market, by Type, 2019-2032 (USD Billion)
    • 8.6.6. Corticosteroids Market - Israel
      • 8.6.6.1. Israel: Corticosteroids Market, by Route of Administration, 2019-2032 (USD Billion)
      • 8.6.6.2. Israel.: Corticosteroids Market, by Application, 2019-2032 (USD Billion)
      • 8.6.6.3. Israel: Corticosteroids Market, by Type, 2019-2032 (USD Billion)
    • 8.6.7. Corticosteroids Market - South Africa
      • 8.6.7.1. South Africa: Corticosteroids Market, by Route of Administration, 2019-2032 (USD Billion)
      • 8.6.7.2. South Africa.: Corticosteroids Market, by Application, 2019-2032 (USD Billion)
      • 8.6.7.3. South Africa: Corticosteroids Market, by Type, 2019-2032 (USD Billion)
  • 8.7. Corticosteroids Market - Latin America
    • 8.7.1. Latin America: Corticosteroids Market, by Route of Administration, 2019-2032 (USD Billion)
    • 8.7.2. Latin America.: Corticosteroids Market, by Application, 2019-2032 (USD Billion)
    • 8.7.3. Latin America: Corticosteroids Market, by Type, 2019-2032 (USD Billion)
    • 8.7.4. Corticosteroids Market - Mexico
      • 8.7.4.1. Mexico: Corticosteroids Market, by Route of Administration, 2019-2032 (USD Billion)
      • 8.7.4.2. Mexico.: Corticosteroids Market, by Application, 2019-2032 (USD Billion)
      • 8.7.4.3. Mexico: Corticosteroids Market, by Type, 2019-2032 (USD Billion)
    • 8.7.5. Corticosteroids Market - Brazil
      • 8.7.5.1. Brazil: Corticosteroids Market, by Route of Administration, 2019-2032 (USD Billion)
      • 8.7.5.2. Brazil.: Corticosteroids Market, by Application, 2019-2032 (USD Billion)
      • 8.7.5.3. Brazil: Corticosteroids Market, by Type, 2019-2032 (USD Billion)
    • 8.7.6. Corticosteroids Market - Argentina
      • 8.7.6.1. Argentina: Corticosteroids Market, by Route of Administration, 2019-2032 (USD Billion)
      • 8.7.6.2. Argentina.: Corticosteroids Market, by Application, 2019-2032 (USD Billion)
      • 8.7.6.3. Argentina: Corticosteroids Market, by Type, 2019-2032 (USD Billion)

9. Competitive Landscape

  • 9.1. Expansion and Acquisition Analysis
    • 9.1.1. Expansion
    • 9.1.2. Acquisitions
  • 9.2. Partnerships/Collaborations/Agreements/Exhibitions

10. Company Profiles

  • 10.1. AbbVie Inc.
    • 10.1.1. Company Overview
    • 10.1.2. Financial Performance
    • 10.1.3. Product Benchmarking
    • 10.1.4. Recent Development
  • 10.2. Astellas Pharma Inc.
    • 10.2.1. Company Overview
    • 10.2.2. Financial Performance
    • 10.2.3. Product Benchmarking
    • 10.2.4. Recent Development
  • 10.3. AstraZeneca plc
    • 10.3.1. Company Overview
    • 10.3.2. Financial Performance
    • 10.3.3. Product Benchmarking
    • 10.3.4. Recent Development
  • 10.4. Bausch Health Companies Inc.
    • 10.4.1. Company Overview
    • 10.4.2. Financial Performance
    • 10.4.3. Product Benchmarking
    • 10.4.4. Recent Development
  • 10.5. Bayer AG
    • 10.5.1. Company Overview
    • 10.5.2. Financial Performance
    • 10.5.3. Product Benchmarking
    • 10.5.4. Recent Development
  • 10.6. Cipla Limited
    • 10.6.1. Company Overview
    • 10.6.2. Financial Performance
    • 10.6.3. Product Benchmarking
    • 10.6.4. Recent Development
  • 10.7. Eli Lilly and Company
    • 10.7.1. Company Overview
    • 10.7.2. Financial Performance
    • 10.7.3. Product Benchmarking
    • 10.7.4. Recent Development
  • 10.8. F. Hoffmann-La Roche Ltd.
    • 10.8.1. Company Overview
    • 10.8.2. Financial Performance
    • 10.8.3. Product Benchmarking
    • 10.8.4. Recent Development
  • 10.9. GlaxoSmithKline plc
    • 10.9.1. Company Overview
    • 10.9.2. Financial Performance
    • 10.9.3. Product Benchmarking
    • 10.9.4. Recent Development
  • 10.10. Johnson & Johnson
    • 10.10.1. Company Overview
    • 10.10.2. Financial Performance
    • 10.10.3. Product Benchmarking
    • 10.10.4. Recent Development
  • 10.11. Lupin Limited
    • 10.11.1. Company Overview
    • 10.11.2. Financial Performance
    • 10.11.3. Product Benchmarking
    • 10.11.4. Recent Development
  • 10.12. Merck & Co., Inc.
    • 10.12.1. Company Overview
    • 10.12.2. Financial Performance
    • 10.12.3. Product Benchmarking
    • 10.12.4. Recent Development
  • 10.13. Novartis International AG
    • 10.13.1. Company Overview
    • 10.13.2. Financial Performance
    • 10.13.3. Product Benchmarking
    • 10.13.4. Recent Development
  • 10.14. Pfizer Inc.
    • 10.14.1. Company Overview
    • 10.14.2. Financial Performance
    • 10.14.3. Product Benchmarking
    • 10.14.4. Recent Development
  • 10.15. Sanofi S.A.
    • 10.15.1. Company Overview
    • 10.15.2. Financial Performance
    • 10.15.3. Product Benchmarking
    • 10.15.4. Recent Development